Clinical Trials
47 trialsOvAR-Y
Washington University School of Medicine
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
iCaRe2
University of Nebraska
TraveraRTGx
Travera Inc
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
EXoPERT EMERALD Clinical Study
EXoPERT
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Memorial Sloan Kettering Cancer Center
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Hi-STEP1
Technische Universität Dresden
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
ROOT
Taproot Health
QUANTUM
VitaMed Research LLC
RADIANT
DxTerity Diagnostics
CONTEST
University of Aarhus
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
POPCORN
Centro di Riferimento Oncologico - Aviano
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Biologics & Biosimilars Collective Intelligence Consortium
Advanced Pelvic Surgical Oncology Database - Prospective Observational Study
Glasgow Royal Infirmary
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Kazakh Medical University of Continuing Education
PASSION
Assistance Publique - Hôpitaux de Paris
SPACE2
Weprom
Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients
Hospital San Carlos, Madrid
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
PIONEER
SpeciCare
CarFlog
University of Pisa
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
N1
CureOne
Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing
Data Collection Analysis Business Management
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Understanding the Value of Community Vital Signs in Primary Care
Virginia Commonwealth University
E3N
Institut National de la Santé Et de la Recherche Médicale, France
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Wake Forest University Health Sciences
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
SPGO Research Mannheim GmbH
Combined Colon and Endometrial Cancer Screening in Women With HNPCC
M.D. Anderson Cancer Center
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Case Comprehensive Cancer Center
GGMI
The Moses H. Cone Memorial Hospital
Hypodontia and Ovarian Cancer
University of Aarhus
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Vanderbilt-Ingram Cancer Center
IRB 2000-294
University of Michigan Rogel Cancer Center
ERAS_feasi
Charite University, Berlin, Germany
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
Mayo Clinic